Fig. 3
From: The use of immunotherapy treatment in malignant pheochromocytomas/paragangliomas: a case report

a Computed tomography scan pre-immunotherapy treatment, b CT restage IO × 5 months, and c CT restage IO × 8 months
From: The use of immunotherapy treatment in malignant pheochromocytomas/paragangliomas: a case report

a Computed tomography scan pre-immunotherapy treatment, b CT restage IO × 5 months, and c CT restage IO × 8 months